-
1
-
-
0028783948
-
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
-
The NINDS Investigators
-
The NINDS Investigators. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-7.
-
(1995)
N Engl J Med
, vol.333
, pp. 1581-1587
-
-
-
2
-
-
52649165720
-
CASS Investigators. Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke
-
Hacke W, Kaste M, Bluhmki E, et al.; CASS Investigators. Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
-
(2008)
N Engl J Med
, vol.359
, pp. 1317-1329
-
-
Hacke, W.1
Kaste, M.2
Bluhmki, E.3
-
3
-
-
79952073474
-
Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: Patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 min
-
Fonarow GC, Smith EE, Saver JL, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 min. Circulation 2011;123:750-8.
-
(2011)
Circulation
, vol.123
, pp. 750-758
-
-
Fonarow, G.C.1
Smith, E.E.2
Saver, J.L.3
-
4
-
-
67650076576
-
Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction
-
De Luca G, Cassetti E, Marino P. Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction. Am J Emerg Med 2009;27:712-19.
-
(2009)
Am J Emerg Med
, vol.27
, pp. 712-719
-
-
De Luca, G.1
Cassetti, E.2
Marino, P.3
-
5
-
-
0345060917
-
Comparison of Angioplasty and Prehospital Thrombolysis in acute Myocardial infarction (CAPTIM) Investigators. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: Data from the CAPTIM randomized clinical trial
-
Steg PG, Bonnefoy E, Chabaud S, et al.; Comparison of Angioplasty and Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) Investigators. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 2003;108:2851-6.
-
(2003)
Circulation
, vol.108
, pp. 2851-2856
-
-
Steg, P.G.1
Bonnefoy, E.2
Chabaud, S.3
-
6
-
-
84877887447
-
Impact of onset-to-reperfusion time on stroke mortality: A collaborative pooled analysis
-
Mazighi M, Chaudhry SA, Ribo M, et al. Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation 2013;127:1980-5.
-
(2013)
Circulation
, vol.127
, pp. 1980-1985
-
-
Mazighi, M.1
Chaudhry, S.A.2
Ribo, M.3
-
7
-
-
70349881711
-
IMS i and II Investigators. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent
-
Khatri P, Abruzzo T, Yeatts SD, et al.; IMS I and II Investigators. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066-72.
-
(2009)
Neurology
, vol.73
, pp. 1066-1072
-
-
Khatri, P.1
Abruzzo, T.2
Yeatts, S.D.3
-
8
-
-
84878420110
-
SWIFT Investigators. Time from symptoms onset to revascularization: Impact on outcomes in revascularized Swift trial patients
-
Zaidat OO, Lazzaro MA, Brown S, et al.; SWIFT Investigators. Time from symptoms onset to revascularization: impact on outcomes in revascularized Swift trial patients. Stroke 2013;44:ATP24.
-
(2013)
Stroke
, vol.44
-
-
Zaidat, O.O.1
Lazzaro, M.A.2
Brown, S.3
-
9
-
-
84893763415
-
IMS III Trialists. Time to angiographic reperfusion is highly associated with good clinical outcome in the IMS III trial
-
February, Honolulu, Hawaii, USA
-
Khatri P, Yeatts SD, Mazighi M, et al.; IMS III Trialists. Time to angiographic reperfusion is highly associated with good clinical outcome in the IMS III trial. Oral Presentation, International Stroke Conference; February 2013, Honolulu, Hawaii, USA.
-
(2013)
Oral Presentation, International Stroke Conference
-
-
Khatri, P.1
Yeatts, S.D.2
Mazighi, M.3
-
10
-
-
84878400988
-
Ultrashort imaging to reperfusion time interval arrests core expansion in endovascular therapy for acute ischemic stroke
-
Almekhlafi MA, Eesa M, Menon BK, et al. Ultrashort imaging to reperfusion time interval arrests core expansion in endovascular therapy for acute ischemic stroke. J Neurointerv Surg 2013;5 (Suppl 1):i58-61.
-
(2013)
J Neurointerv Surg
, vol.5
, Issue.SUPPL. 1
-
-
Almekhlafi, M.A.1
Eesa, M.2
Menon, B.K.3
-
11
-
-
84874949254
-
Picture to puncture: A novel time metric to enhance outcomes in patients transferred for endovascular reperfusion in acute ischemic stroke
-
Sun CH, Nogueira RG, Glenn BA, et al. "Picture to puncture": a novel time metric to enhance outcomes in patients transferred for endovascular reperfusion in acute ischemic stroke. Circulation 2013;127:1139-48.
-
(2013)
Circulation
, vol.127
, pp. 1139-1148
-
-
Sun, C.H.1
Nogueira, R.G.2
Glenn, B.A.3
-
12
-
-
33644874026
-
Time is brain-quantified
-
Saver JL. Time is brain-quantified. Stroke 2006;37:263-6.
-
(2006)
Stroke
, vol.37
, pp. 263-266
-
-
Saver, J.L.1
-
13
-
-
84867551015
-
Developing practice recommendations for endovascular revascularization for acute ischemic stroke
-
Lazzaro MA, Novakovic RL, Alexandrov AV, et al. Developing practice recommendations for endovascular revascularization for acute ischemic stroke. Neurology 2012;79(Suppl 1):S243-55.
-
(2012)
Neurology
, vol.79
, Issue.SUPPL. 1
-
-
Lazzaro, M.A.1
Novakovic, R.L.2
Alexandrov, A.V.3
-
14
-
-
84870955513
-
Reducing door-to-needle times using Toyota's lean manufacturing principles and value stream analysis
-
Ford AL, Williams JA, Spencer M, et al. Reducing door-to-needle times using Toyota's lean manufacturing principles and value stream analysis. Stroke 2012;43:3395-8.
-
(2012)
Stroke
, vol.43
, pp. 3395-3398
-
-
Ford, A.L.1
Williams, J.A.2
Spencer, M.3
|